<DOC>
<DOCNO>EP-0648758</DOCNO> 
<TEXT>
<INVENTION-TITLE>
4-Arylamino-benzopyran and related compounds.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3135	A61K3135	A61K31352	A61K31352	A61K31353	A61K3138	A61K3138	A61K31415	A61K31415	A61K3142	A61K3142	A61K31425	A61K31425	A61K31435	A61K31435	A61K3144	A61K3144	A61K314427	A61K31443	A61K31495	A61K31495	A61K31535	A61K31535	A61P100	A61P100	A61P900	A61P906	A61P908	A61P910	A61P912	A61P1100	A61P1108	A61P1300	A61P1302	A61P1500	A61P1500	A61P2500	A61P2500	C07C21100	C07C21142	C07C21500	C07C21544	C07C23300	C07C23311	C07D31100	C07D31162	C07D31168	C07D31170	C07D40500	C07D40504	C07D40512	C07D40514	C07D40700	C07D40712	C07D41300	C07D41312	C07D41314	C07D41700	C07D41704	C07D41712	C07D41714	C07D47100	C07D47104	C07D48700	C07D48702	C07D49100	C07D491052	C07D49500	C07D49504	C07F900	C07F9655	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07C	C07C	C07C	C07C	C07C	C07C	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P1	A61P1	A61P9	A61P9	A61P9	A61P9	A61P9	A61P11	A61P11	A61P13	A61P13	A61P15	A61P15	A61P25	A61P25	C07C211	C07C211	C07C215	C07C215	C07C233	C07C233	C07D311	C07D311	C07D311	C07D311	C07D405	C07D405	C07D405	C07D405	C07D407	C07D407	C07D413	C07D413	C07D413	C07D417	C07D417	C07D417	C07D417	C07D471	C07D471	C07D487	C07D487	C07D491	C07D491	C07D495	C07D495	C07F9	C07F9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Compounds having the formula 

and pharmaceutically acceptable salts thereof wherein X is alkyl, Y is a 
single bond, -CH₂-, -C(O)-, -O-, -S- or -N(R⁸)- where R⁸ is hydrogen, 

alkyl, haloalkyl, aryl, arylalkyl, cycloalkyl or (cycloalkyl)alkyl, and R¹ to 
R⁷ are as defined herein. These compounds have potassium channel 

activating activity and are useful, therefore for example, as cardiovascular 
agents. 
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SQUIBB BRISTOL MYERS CO
</APPLICANT-NAME>
<APPLICANT-NAME>
BRISTOL-MYERS SQUIBB COMPANY
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ATWAL KARNAIL
</INVENTOR-NAME>
<INVENTOR-NAME>
DING CHARLES Z
</INVENTOR-NAME>
<INVENTOR-NAME>
ROVNYAK GEORGE C
</INVENTOR-NAME>
<INVENTOR-NAME>
SANTAFIANOS DINOS P
</INVENTOR-NAME>
<INVENTOR-NAME>
ATWAL, KARNAIL
</INVENTOR-NAME>
<INVENTOR-NAME>
DING, CHARLES Z.
</INVENTOR-NAME>
<INVENTOR-NAME>
ROVNYAK, GEORGE C.
</INVENTOR-NAME>
<INVENTOR-NAME>
Santafianos, Dinos P.
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
This application is a continuation-in-part of U.S. application serial 
No. 08/134,034, filed October 7, 1993; incorporated by reference herein. The present invention is directed to compounds of the formula 
and pharmaceutically acceptable salts thereof. As used in formula I, and 
throughout the specification, the symbols have the following meanings:
 
   a, b and d are all carbon atoms or one of a, b and d is a 
nitrogen atom or -N(O)- and the others are carbon atoms;
 
   Y is a single bond, -CH₂-, -C(O)-, -O-, -S-or -N(R⁸)-;
 
   R¹ is aryl or heterocyclo;
 
   R² is -COOR⁸, -CO-amino, -CO-substituted amino, amino, 
substituted amino, -NR₈CO-amino, -NR₈CO-substituted amino, -NR⁸COR⁹, 
-NR⁸SO₂R⁹, -NR⁸(C=NCN)-amino, -NR⁸(C=NCN)-substituted amino, 
-SR⁸, -SOR⁸, -SO₂R⁸, -OR⁸, cyano, heterocyclo, pyridine-N-oxide, 
-CH(OR⁸)₂, 
(where Z is O or 
H₂) or 
   R³ is hydrogen, hydroxy or -OC(O)R⁸;
 
   R⁴ and R⁵ are each independently hydrogen, alkyl or 
arylalkyl, or R⁴ and R⁵ taken together with the carbon atom to which they 
are attached form a 5- to 7-membered carbocyclic ring;
 
   R⁶ is hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, 
cycloalkyl, arylalkyl, (cycloalkyl)alkyl, -CN, -NO₂, -COR⁸, -COOR⁸, 
-CONHR⁸, -CONR⁸R⁹, -CF₃, -S-alkyl, -SOalkyl, -SO₂alkyl, 
halogen, amino, substituted amino, -O-alkyl, -OCF₃, 
-OCH₂CF₃, -OCOalkyl, -OCONR⁸alkyl, -NR⁸COalkyl, -NR⁸COOalkyl 
or -NR⁸CONR⁹, tetrazolyl, imidazole, oxazole or triazole;
 
   R⁷ is hydrogen, alkyl, hydroxy, -O-alkyl, amino, 
substituted amino, -NHCOR₈, -CN or -NO₂;
 
   R⁸ and R⁹ are independently hydrogen, alkyl, haloalkyl, 
aryl, arylalkyl, cycloalkyl or (cycloalkyl)alkyl;
 
   X is alkyl; or X-R² together can be hydrogen, aryl or 
heterocyclo when R¹ is heterocyclo; and
 
   n is an integer of 1 to 3. The compounds of this invention possess antiischemic activity and 
are useful. for example as cardiovascular agents. The present invention provides for compounds of formula I, 
pharmaceutical compositions employing such compounds and for methods 
of using such compounds. Listed below are definitions of various terms 
used to describe the compounds of the instant invention. These definitions 
apply to the terms as they are used throughout the specification (unless  
 
they are otherwise limited in specific instances either individually or as 
part of a larger group). The term "alkyl" refers to both straight and branched chain groups 
having 1 to 8 carbon atoms preferably 1 to 5 carbons, such as methyl, 
ethyl, propyl, butyl, pentyl, hexyl, heptyl,
</DESCRIPTION>
<CLAIMS>
A compound of the formula 
 

or such a compound in pharmaceutically acceptable salt 
form, wherein 

   a, b and d are all carbon atoms or one of a, b and d is a 
nitrogen atom or -N(O)- and the others are carbon atoms; 

   Y is a single bond, -CH₂-, -C(O)-, -O-, -S- or -N(R⁸)-; 
   R¹ is aryl or heterocyclo; 

   R² is -COOR⁸, -CO-amino, -CO-substituted amino, amino, 
substituted amino, -NR⁸CO-amino, -NR⁸CO-substituted amino, -NR⁸COR⁹, 

-NR⁸SO₂R⁹, -NR⁸(C=NCN)-amino, -NR⁸(C=NCN)-substituted amino, 
 

-SR⁸, -SOR⁸, -SO₂R⁸, -OR⁸, cyano, heterocyclo, pyridine-N-oxide, 
-CH(OR⁸)₂, 

 
(where Z is O or 

H₂) or 
 

   R³ is hydrogen, hydroxy or -OC(O)R⁸; 
   R⁴ and R⁵ are each independently hydrogen, alkyl or 

arylalkyl, or R⁴ and R⁵ taken together with the carbon atom to which they 
are attached form a 5- to 7-membered carbocyclic ring; 

   R⁶ is hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, 
cycloalkyl, arylalkyl, (cycloalkyl)alkyl, -CN, -NO₂, -COR⁸, -COOR⁸, 

-CONHR⁸, -CONR⁸R⁹, -CF₃, -S-alkyl, -SOalkyl, -SO₂alkyl, 
 

halogen, amino, substituted amino, -O-alkyl, -OCF₃, 
-OCH₂CF₃, -OCOalkyl, -OCONR⁸alkyl, -NR⁸COalkyl, -NR⁸COOalkyl 

or -NR⁸CONR⁹, tetrazolyl, imidazole, oxazole or triazole; 
   R⁷ is hydrogen, alkyl, hydroxy, -O-alkyl, amino, 

substituted amino, -NHCOR⁸, -CN or -NO₂; 
   R⁸ and R⁹ are independently hydrogen, alkyl, haloalkyl, 

aryl, arylalkyl, cycloalkyl or (cycloalkyl)alkyl; 
   X is alkyl; or X-R² together can be hydrogen, aryl or 

heterocyclo when R¹ is heterocyclo; and 
   n is an integer of 1 to 3. 
A compound of Claim 1 wherein 
   a, b and d are carbon atoms; 

   X is alkyl; 
   Y is a single bond or -O-; 

   R¹ is aryl or heterocyclo; 
   R² is -COOR⁸, -COamino, -CO-substituted amino, 

-NHCOCH₃, -NHSO₂Me, -NHCONH₂, -NH(C=NCN)NH₂, imidazole, 
furan, pyridine, oxazole, hydroxy, -NHCO-substituted amino or -SO₂Me; 

   R³ is hydroxy; 
   R⁴ and R⁵ are methyl; 

   R⁶ is cyano, -NO₂, -CF₃, halo, alkyl or tetrazol; and 
   R⁷ is hydrogen. 
A compound of Claim 1, which is: 
   trans-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
acetic 
acid, ethyl ester, 

   (3S-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]acetic 

acid, ethyl ester, 
   (3R-trans
)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]acetic 

acid, ethyl ester; 
   trans-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
acetic 
acid;

 
   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-fluorophenyl)amino]
acetic 
acid, ethyl ester, 

   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-chlorophenyl)amino]acetic 

acid, ethyl ester, 
   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
acetamide; 
   (3S-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(4-phenyl-2-thiazolyl)amino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(4-phenyl-2-thiazolyl)amino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-[N-[3,4-dihydro-3-hydroxy-2,2-dimethyl-6-(1H-tetrazol-5-yl)-2H-1-benzopyran-4-yl]
phenylamino]acetic 

acid, ethyl ester; 
   (3R-trans)-2[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
-N-ethylacetamide; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N[2-(1-pyrrolidinyl)-2-oxoethyl]
phenylamino]-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N[2-(4-morpholinyl)-2-oxoethyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-[N-(6-cyano-3 ,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
-N-(2-furanylmethyl)acetamide; 
   (3R-trans)-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
-N-[2-(4-morpholinyl)ethyl]acetamide; 

   (3R-trans)-4-[(4-fluorophenyl)(2-hydroxy-2-methylpropyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   [3R-[3a,4b(R*)]]-4-[(4-fluorophenyl)(2-hydroxypropyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-methyl-2-thiazolyl)amino]
acetic 
acid, ethyl ester; 

   (3R-trans)-4-[N-(2-benzoxazolyl)-N-(2,2-dimethoxyethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[N-[1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl]phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile;
 

   (3R-trans)-4-[N-(2-aminoethyl)phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]butyric 

acid, ethyl ester; 
   (3R-trans)-3-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
propanoic 
acid, ethyl ester; 

   (3R-trans)-3,4-dihydro-3-hydroxy-4-[N-[(1H-imidazol-2-yl)methyl]phenylamino]
-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[[2-(acetylamino)ethyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino)ethyl]urea; 

   (3R-trans)-N-[2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]ethyl]
methanesulfonamide; 
   (3R-trans)-N''-cyano-N-[2-[[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
ethyl]guanidine; 

   (3R-trans)-2[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]-N-(2-hydroxyethyl)acetamide; 

   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[4-fluoro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

mono hydrochloride; 
   (3R-trans)-4-[N-(2-furanylmethyl)phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[N-(2-furanylmethyl)phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[N-[(4,5-dihydro-2-oxazolyl)methyl]
phenylamino]3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[(2-benzoxazolyl)(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4yl)amino]acetic 

acid, ethyl ester, 
   (3R-trans)-4-[(2-benzoxazolyl)(2-pyridinylethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile;
 

   (3R-trans)-4-[(2-benzoxazolyl)(2-furanomethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[(2-furanylmethyl)(2-oxazolyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[N-(cyanomethyl)phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[N-(cyanoethyl)phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-4-[N-(2-methoxyethyl)phenylamino]-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-cis)-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]-N-ethyl-acetamide; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[(5-methyl-3-isoxazolyl)methyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-fluorophenyl)[(5-methyl-3-isoxazolyl)methyl]
amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3S-cis)-2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]-N-ethyl-acetamide; 

   (3R-trans)-[[[5-[[(3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-fluorophenyl)amino]methyl]
-2-furanyl]methyl]
amino]acetic 

acid, ethyl ester, monohydrochloride; 
   (3R-trans)-4-[(4-fluorophenyl)[[5-(hydroxymethyl)-2-furanyl]
methyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
acetic 
acid, n-butyl ester; 

   (3R-trans)-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]-N-phenylacetamide; 

   (3R-trans)-4-[N-(2-furanylmethyl)phenylamino]-3,4-dihydro-2,2-dimethyl-6-(1H-tetrazol-5-yl)-2H-1-benzopyran-3-ol; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N-[(5-methyl-3-isoxazolyl)methyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile;
 

   (3S-trans)-3,4-dihydro-3-hydroxy-4-[N-[(1H-imidazol-2-yl)methyl]phenylamino]
-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N-(2-oxazolylmethyl)phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-2[[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
methyl]-4-oxazolecarboxylic 

acidethyl ester; 
   (3R-trans)-2[[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
methyl]-4-oxozolecarboxylic 

acid 
mono sodium salt; 

   (S*,R*)-N-[[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]acetyl]
-L-serine, 
methyl ester; 

   (3R-trans)-4[N-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-chlorophenyl)(2-oxazolylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[N-(1H-benzimidazol-2-ylmethyl)phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4[(2-benzoxazolyl)[2-(4-morpholinyl)ethyl]
amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[(2-furanylmethyl)(2-pyrimidinyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(2-pyrazinyl)-(3-pyridinylmethyl)amino]-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[(3-pyridinylmethyl)(2-pyridinyl)amino]-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[(2-benzoxazolyl)(2-pyridinylmethyl)-amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran
-6-carbonitrile; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[(2-pyrimidinyl)(2-pyridinylmethyl)amino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-fluorophenyl)(2-pyridinylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile;
 

   4-[4-fluoro-N-(1H-imidazol-2-ylmethyl)phenylamino]-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4-[(4-fluorophenyl)(2-pyrimidinyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

monohydrochloride; 
   (3R-trans)-4-[(2-furanylmethyl)(2-pyrazinyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(2-benzothiazolyl)(3-pyridinylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-fluorophenyl)(3-pyridinylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(2-benzothiazolyl)(3-pyridinylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 
1-oxide; 

   (3R-trans)-4-[(4-chlorophenyl)[2-(4-morpholinyl)ethyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 
monohydrochloride; 

   (3R-trans)-4-[(4-fluorophenyl)[2-(4-morpholinyl)ethyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 
monohydrochloride; 

   (3R-trans)-4-[(6-chloro-3-pyridazinyl)[2-(4-morpholinyl)ethyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 
hydrochloride; 

   (3R-trans)-4[(2-benzothiazolyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

monohydrochloride; 
   (3R-trans)-4-[(6-chloro-3-pyridazinyl)(1H-imidazol-2-ylmethyl)amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 
monohydrochloride; 

   (3R-trans)-4[(5-trifluoromethyl-2-pyridinyl))(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

monohydrochloride;
 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[[2-(4-morpholinyl)ethyl](4-phenyl-2-thiazolyl)amino]
-2H-1-benzopyran-6-carbonitrile, 
monohydrochloride; 

   (3R-trans)-3,4-dihydro-3-hydroxy-4-[(1H-imidazol-2-ylmethyl)(4-phenyl-2-thiazolyl)amino]-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-4-[(1H-imidazol-2-yl-methyl)-(4-methyl-2-thiazolyl)amino]-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-N-[2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]ethyl]
-2,2-dimethyl-propanamide; 
   (3R-trans)-N-[2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]
ethyl]-N'-phenylurea; 

   (3R-trans)-N-[2-[N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]ethyl]
-1-pyrrolidine-carboxamide; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[(2-oxo-1-pyrrolidinyl)ethyl)phenyl]
amino]-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-fluorophenyl)amino]methyl]
phosphonic 
acid, 

diethyl ester; 
   [N-(4-clorophenyl)-N-(6-cyano-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)amino]
acetic 
acid, ethyl ester; 

   4-[(4-clorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-chlorophenyl)[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]
amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-4[(4-fluorophenyl)[(3-methyl-1,2,4-oxadiazol-5-ylmethyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile;
 

   (3R-trans)-[N-[3,4-dihydro-3-hydroxy-2,2-dimethyl-7-(trifluoromethyl)-2H-1-benzopyran-4-yl]phenylamino]
acetic 
acid, ethyl 

ester; 
   (3R-trans)-3,4-dihydro-3-hydroxy-4-[N-[[3-(hydroxymethyl)-1,2,4-oxadiazol-5-yl)methyl]
phenylamino]-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[N-[3,4-dihydro-3-hydroxy-2,2-dimethyl-8-(trifluoromethyl)-2H-1-benzopyran-4-yl]phenylamino]
acetic 
acid, ethyl 

ester; 
   (3R-trans)-4-[(4-chlorophenyl)[[3-(hydroxymethyl)-1,2,4-oxadiazol-5-yl]
methyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-fluorophenyl)[[3-(hydroxymethyl)-1,2,4-oxadiazol-5-yl]
methyl]amino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4[N-[(3-amino-1,2,4-oxadiazol-5-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-[N-(6-benzoyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)phenylamino]acetic 

acid, ethyl ester; 
   (3R-trans)-[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)[4-fluoro-3-[(phenylmethoxy)carbonyl]
phenyl]amino]
acetic 
acid, ethyl ester; 

   (3R-trans)-[[5-[[(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)(4-fluorophenyl)amino]methyl]
-1,2,4-oxadiazol-3-yl]methoxy]
acetic 
acid; 

   (3R-trans)-[[5-[[(4-chlorophenyl)(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)amino]methyl]
-1,2,4-oxadiazol-3-yl]methoxy]
acetic 
acid; 

   (3R-trans)-[(3-carboxy-4-fluorophenyl)(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)amino]acetic 

acid, ethyl 
ester;

 
   (3R-trans)-4-[(4-fluorophenyl)[(2-methyl-2H-tetrazol-5-yl)methyl]
amino-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[(4-fluorophenyl)[(1-methyl-1H-tetrazol-5-yl)methyl]
amino-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[2-methylsulfinyl)ethyl]
phenylamino]-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[2-(methylsulfonyl)ethyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

monohydrochloride; 
   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

hydrogensulfate; 
   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

methanesulfonate; 
   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

phosphate; 
   (3R-trans)-4-[4-chloro-N-[(1H-imidazol-2-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile, 

nitrate; 
   [3R-[3a,4β(R*)]]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-4[N-[[5-oxo-1-(phenylmethyl)-2-pyrrolidinyl]methyl]
phenylamino]-2H-1-benzopyran-6-carbonitrile; 

   [3R-[3α,4β(S*)]]-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N-[[5-oxo-2-pyrrolidinyl)methyl]
phenylamino]-2H-1-benzopyran-6-carbonitrile; 

   [3R-[3α,4β(R*)]]-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N-[(5-oxo-2-pyrrolidinyl)methyl]
phenylamino]-2H-1-benzopyran-6-carbonitrile;

 
   (3R-trans)-4[N-[(1,5-dimethyl-1H-pyrazol-3-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   (3R-trans)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-[N-[(5-methyl-1H-pyrazol-3-yl)methyl]phenylamino]
-2H-1-benzopyran-6-carbonitrile; 
   (3R-trans)-4-[N-[(1,3-dimethyl-1H-pyrazol-5-yl)methyl]
phenylamino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 

   [3R-[3α,4β-(Z)]]-4-[N-(2-amino-4-oxo-2-pentenyl)phenylamino]
-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile; 
or a pharmaceutically acceptable salt thereof. 
A pharmaceutical composition comprising a compound of 
Claim 1, 2 or 3 and a pharmaceutically acceptable carrier. 
A compound of the formula 

 
or pharmaceutically acceptable salts thereof wherein 

   a, b and d are all carbon atoms or one of a, b and d is a 
nitrogen atom or -N(O)- and the others are carbon atoms; 

   Y is a single bond, -CH₂-, -C(O)-, -O-, -S- or -N(R)- 
where R is hydrogen, alkyl, haloalkyl, aryl, arylalkyl, cycloalkyl or 

(cycloalkyl)alkyl; 
   R¹ is aryl or heterocyclo; 

   R² is -COOR, -CO-amino, -CO-substituted amino, amino, 
substituted amino, -NRCO-amino, -NRCO-substituted amino, -NRCOR, 

-NRSO₂R, -NR(C=NCN)-amino, -NR(C=NCN)-substituted amino, 

 

-SR, -SOR, -SO₂R, -OR, cyano, heterocyclo, -CH(OR)₂, 
 

(where Z is O or H₂); 
   R³ is hydrogen, hydroxy or -OC(O)R; 

   R⁴ and R⁵ are each independently hydrogen, alkyl or 
arylalkyl, or R⁴ and R⁵ taken together with the carbon atom to which they 

are attached form a 5- to 7-membered carbocyclic ring; 
   R⁶ is hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, 

cycloalkyl, arylalkyl, (cycloalkyl)alkyl, -CN, -NO₂, -COR, -COOR, 
-CONHR, -CON(R)₂, -CF₃, -S-alkyl, -SOalkyl, SO₂alkyl; 

 
halogen, amino, substituted amino, -O-alkyl, -OCF₃, 

-OCH₂CF₃, -OCOalkyl, -OCONRalkyl, -NRCOalkyl, -NRCOOalkyl or 
-NRCONR, tetrazolyl, imidazole, oxazole or triazole; 

   R⁷ is hydrogen, alkyl, hydroxy, -O-alkyl, amino, 
substituted amino, -NHCOR, -CN or -NO₂; 

   X is alkyl; or X-R² together are hydrogen, aryl or 
heterocyclo when R¹ is heterocyclo; and 

   n is an integer of 1 to 3. 
A compound of Claim 1, 2, 3 or 5 for use as an active 
pharmaceutical substance. 
Use of a compound of Claim 1, 2, 3 or 5 for the 
manufacture of a medicament for treatment of conditions 

requiring potassium channel activation. 
Use of a compound of Claim 1, 2, 3 or 5 for the 
manufacture of a medicament for treatment of ischemia. 
</CLAIMS>
</TEXT>
</DOC>
